Results
16
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
16 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
YDOA | €25.60 | 0% | -3.8% | €156.7m | n/a | PB4.6x | n/a | 3.6% | Real Estate | ||
YZBL | €0.94 | 0% | -15.0% | €603.6m | n/a | PB0.8x | n/a | 3.8% | Real Estate | ||
CBAV | €35.10 | -1.4% | 68.8% | €572.2m | n/a | PE14.9x | n/a | 4.5% | Healthcare | ||
SCHST | €12.40 | 0% | n/a | €619.6m | n/a | PB2.3x | n/a | n/a | Real Estate | ||
PRO | €32.40 | -4.7% | 85.1% | €1.5b | n/a | PE42.5x | n/a | 2.8% | Consumer Services | ||
R4 | €12.90 | 1.6% | 24.0% | €524.9m | n/a | PE19.3x | n/a | 3.8% | Diversified Financials | ||
SCBYT | €5.40 | -1.8% | n/a | €161.9m | n/a | PE50.4x | n/a | n/a | Consumer Services | ||
MCM | €12.30 | -1.6% | 11.0% | €469.6m | n/a | PE10.1x | n/a | 3.7% | Materials | ||
PRM | €10.10 | 3.7% | -4.3% | €171.9m | €16.75 | PE15x | n/a | 4.4% | Healthcare | ||
RLIA | €1.00 | -1.0% | -5.7% | €811.1m | €1.12 | PE22x | n/a | 5.0% | Real Estate Management and Development | ||
CMO | €24.00 | 0% | 33.3% | €1.5b | €28.20 | PE8.4x | n/a | 4.3% | Materials | ||
GSJ | €4.65 | -1.5% | 29.5% | €302.4m | €9.62 | PE9x | E-7.7% | 3.2% | Capital Goods | ||
CEV | €7.40 | 0% | 20.3% | €171.4m | n/a | PE9.9x | E-10.5% | 3.0% | Real Estate Management and Development | ||
ART | €6.15 | 0.8% | 60.2% | €350.5m | €6.97 | PE23.1x | E28.8% | 1.7% | Capital Goods | ||
ENO | €19.58 | 0.6% | 12.5% | €1.7b | €26.40 | PE36.3x | E-30.1% | 33.7% | Capital Goods | ||
FAE | €3.47 | -1.3% | 10.3% | €1.1b | €3.75 | PE11.1x | E-2.8% | 4.5% | Pharmaceuticals & Biotech |